| 21st March 2016 02:57 PM | |
| Shaleen | Re: Eu aims imi European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS) - is the Largest Single Grant for Autism in the world, And the Largest for the Study of any Mental Health Disorder in Europe EU-AIMS Involves a Novel Collaboration Between organizations Representing Affected Individuals and their families (Autism Speaks), academia and Industry who for the first time in the world have come together to develop the infrastructure underpinning new treatments for autism. Patient organizations, academic and industry join forces to develop and assess novel treatment approaches for autism. EU-AIMS Collaborates with other groups and projects to improve quality of life and prognosis for people with autism: The European Babysibs Autism Research Network (Eurosibs) Autism Spectrum Disorders in Europe (ASDEU) Participants : EFPIA F. Hoffmann-la Roche AG, Basel, Switzerland Eli Lilly and Company Ltd, Basingstoke, UK Institut de Recherches Servier, Suresnes, France Janssen Pharmaceutica NV, Beerse, Belgium Pfizer Ltd, Sandwich, UK Vifor SA, Villars-sur-Glâne, Switzerland Contact Details : Tel: +41 61 688 6350 E-mail: will.spooren[AT]roche.com Address : King's College London Strand London WC2R 2LS United Kingdom |
| 21st March 2016 02:57 PM | |
| Unregistered | Eu aims imi Hii Buddy , I want to Get information about King's College London European Autism Interventions Innovative Medicines Initiative , Can you please Give me Same Details ? |
